Literature DB >> 20180667

Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples.

H E Jones1, S H Heil, K E O'Grady, P R Martin, K Kaltenbach, M G Coyle, S M Stine, P Selby, A M Arria, G Fischer.   

Abstract

BACKGROUND: Little is known about the prevalence and severity of smoking in pregnant opioid dependent patients.
OBJECTIVES: To first characterize the prevalence and severity of smoking in pregnant patients screened for a randomized controlled trial, Maternal Opioid Treatment: Human Experimental Research (MOTHER), comparing two agonist medications; and second, to compare the MOTHER screening sample to published samples of other pregnant and/or patients with substances use disorders.
METHODS: Pregnant women (N = 108) screened for entry into an agonist medication comparison study were retrospectively compared on smoking variables to samples of pregnant methadone-maintained patients (N = 50), pregnant opioid or cocaine dependent patients (N = 240), non-pregnant methadone-maintained women (N = 75), and pregnant non-drug-addicted patients (N = 1,516).
RESULTS: Of screened patients, 88% (n = 95) smoked for a mean of 140 months (SD = 79.0) starting at a mean age of 14 (SD = 3.5). This rate was similar to substance use disordered patients and significantly higher compared to general pregnant patients (88% vs. 22%, p < .001). CONCLUSION AND SCIENTIFIC SIGNIFICANCE: Aggressive efforts are needed to reduce/eliminate smoking in substance-abusing pregnant women.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20180667      PMCID: PMC2925409          DOI: 10.1080/00952990903125235

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  21 in total

1.  Smoking during pregnancy and intention to quit: a profile of methadone-maintained women.

Authors:  N A Haug; M L Stitzer; D S Svikis
Journal:  Nicotine Tob Res       Date:  2001-11       Impact factor: 4.244

Review 2.  Pharmacotherapy for smoking cessation during pregnancy.

Authors:  Neal Benowitz; Delia Dempsey
Journal:  Nicotine Tob Res       Date:  2004-04       Impact factor: 4.244

3.  Predictors of smoking in pregnancy and attitudes and knowledge of risks of pregnant smokers.

Authors:  R A Walsh; S Redman; M W Brinsmead; J L Fryer
Journal:  Drug Alcohol Rev       Date:  1997-03

4.  Smokers may pay, but not their own way.

Authors:  P Cotton
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

5.  Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

Authors:  K O Fagerström
Journal:  Addict Behav       Date:  1978       Impact factor: 3.913

6.  Characterizing pregnant drug-dependent women in treatment and their children.

Authors:  W B Kissin; D S Svikis; G D Morgan; N A Haug
Journal:  J Subst Abuse Treat       Date:  2001-07

7.  The effects of high and low doses of methadone on cigarette smoking.

Authors:  J M Schmitz; J Grabowski; H Rhoades
Journal:  Drug Alcohol Depend       Date:  1994-02       Impact factor: 4.492

8.  Patterns of smoking and methadone dose in drug treatment patients.

Authors:  Kimber P Richter; Ashley K Hamilton; Sandra Hall; Delwyn Catley; Lisa S Cox; James Grobe
Journal:  Exp Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.157

9.  Psychosocial and spiritual factors associated with smoking and substance use during pregnancy in African American and White low-income women.

Authors:  D Elizabeth Jesse; Marilyn Graham; Mel Swanson
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2006 Jan-Feb

Review 10.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14
View more
  26 in total

Review 1.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 2.  Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.

Authors:  Sarah C Akerman; Mary F Brunette; Alan I Green; Daisy J Goodman; Heather B Blunt; Sarah H Heil
Journal:  J Subst Abuse Treat       Date:  2014-12-22

Review 3.  Reducing tobacco use among women of childbearing age: Contributions of tobacco regulatory science and tobacco control.

Authors:  Allison N Kurti
Journal:  Exp Clin Psychopharmacol       Date:  2019-12-19       Impact factor: 3.157

Review 4.  Developmental opioid exposures: Neurobiological underpinnings, behavioral impacts, and policy implications.

Authors:  Samantha S Goldfarb; Gregg D Stanwood; Heather A Flynn; Devon L Graham
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-20

5.  Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes.

Authors:  Hendrée E Jones; Sarah H Heil; Michelle Tuten; Margaret S Chisolm; Julianne M Foster; Kevin E O'Grady; Karol Kaltenbach
Journal:  Drug Alcohol Depend       Date:  2012-12-29       Impact factor: 4.492

Review 6.  The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.

Authors:  Jason R Pryor; Faouzi I Maalouf; Elizabeth E Krans; Robert E Schumacher; William O Cooper; Stephen W Patrick
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2017-01-10       Impact factor: 5.747

Review 7.  Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review.

Authors:  Jennifer N Lind; Julia D Interrante; Elizabeth C Ailes; Suzanne M Gilboa; Sara Khan; Meghan T Frey; April L Dawson; Margaret A Honein; Nicole F Dowling; Hilda Razzaghi; Andreea A Creanga; Cheryl S Broussard
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

8.  Illicit drug use among pregnant women enrolled in treatment for cigarette smoking cessation.

Authors:  Diann E Gaalema; Stephen T Higgins; Christopher S Pepin; Sarah H Heil; Ira M Bernstein
Journal:  Nicotine Tob Res       Date:  2012-10-15       Impact factor: 4.244

9.  A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine.

Authors:  Margaret S Chisolm; Heather Fitzsimons; Jeannie-Marie S Leoutsakos; Shauna P Acquavita; Sarah H Heil; Molly Wilson-Murphy; Michelle Tuten; Karol Kaltenbach; Peter R Martin; Bernadette Winklbaur; Lauren M Jansson; Hendrée E Jones
Journal:  Nicotine Tob Res       Date:  2013-01-03       Impact factor: 4.244

10.  Cigarette Smoking and Neonatal Outcomes in Depressed and Non-Depressed Opioid-Dependent Agonist-Maintained Pregnant Patients.

Authors:  Margaret S Chisolm; Shauna P Acquavita; Karol Kaltenbach; Bernadette Winklbaur; Sarah H Heil; Peter R Martin; Susan M Stine; Mara Coyle; Jeannie-Marie S Leoutsakos; Michelle Tuten; Lauren M Jansson; Penina M Backer; Hendrée E Jones
Journal:  Addict Disord Their Treat       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.